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Abstract
Background: Clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) is a clinico-radiological
syndrome characterized by transient mild symptoms of encephalopathy and a reversible lesion in the splenium of the
corpus callosum on magnetic resonance imaging (MRI). It is often triggered by infection. The common pathogens of
MERS are viruses, especially influenza virus. However, Mycoplasma pneumoniae (M.pneumoniae) are relatively rare
pathogens for MERS.
Case presentation: Here we report two paediatric cases of M.pneumoniae infection-induced MERS. The diagnosis of M.
pneumoniae infection was established based on polymerase chain reaction (PCR) and specific serum antibodies (IgM).
Both of the two patients presented with mild encephalopathy manifestations and recovered completely within a few
days. The initial MRI showed a lesion in the central portion of the splenium of the corpus callosum, which completely
resolved on the seventh and eighth day after admission for case 1 and case 2. Lumbar puncture was performed in both
patients, which revealed no pleocytosis. In case 1, the patient had hyponatremia, peripheral facial nerve paralysis, and
rash. To the best of our knowledge, it is the first MERS case associated with peripheral nerve damage. In case 2,
interleukin-6(IL-6) was moderately increased in the cerebrospinal fluid (CSF). It suggested that IL-6 may play a role in the
pathogenesis of M.pneumoniae-induced MERS.
Conclusion: Our study enriches the available information on the pathogens of MERS and provides valuable data for
better understanding of this syndrome.
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Background
Clinically mild encephalitis/encephalopathy with a re-
versible splenial lesion (MERS) is a clinico-radiological
syndrome, which was first reported by Tada et al. in 2004
[1] and further enriched by Takanashi et al [2]. The most
common clinical feature is a neurological dysfunction,
including delirious behavior, consciousness disturbance,
and seizures, all of which recover completely within
1 month [2]. Typical magnetic resonance imaging (MRI)
findings of MERS include damage to the splenium of the
corpus callosum in the acute phase, and sometimes dam-
age spread to the whole corpus callosum and adjacent
white matter. The corpus callosum connects the two
cerebral hemispheres, and the splenium is located in the
corpus callosum backend. The high-signal lesions are typ-
ically symmetrical and notable without enhancement on
T2- and diffusion-weighted sequences, especially on the
diffusion-weighted sequence. Lesions on the MRI images
often disappear in 1 week or a few weeks [1, 2].
MERS may affect adults and children. Its pathogenesis
is not clear and often triggered by infection. The most
common pathogen is influenza virus A and B, and others
include rotavirus, measles virus, adenovirus, Streptococcus,
and Escherichia coli [3]. Mycoplasma pneumoniae
(M.pneumoniae) infection-related MERS is rare [4–6],
and MERS has not been previously mentioned in the lit-
erature among M.pneumoniae-related central nervous
system (CNS) dysfunction [7]. Here, we report 2 cases of
M.pneumoniae infection-induced MERS to enrich the
available information on the pathogens of MERS and the
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A 9-year-old male patient was admitted to the hospital be-
cause of fever for 2 days, and headache, vomiting, mouth
drooping on the right side, and rash for 1 day. Physical
examination showed a body temperature of 38.7 °C and
otherwise normal vital signs. Red maculopapular rashes
that faded under pressure were scattered all over the body.
Neurological examination showed poor mental status and
obvious lethargy. Cranial nerve examination revealed
mouth drooping on the right side, incomplete eyelid clos-
ure and shallow nasolabial sulcus on the left side because
of the left peripheral facial paralysis, which is known to be
associated with M.pneumoniae infection. Meningeal irrita-
tion and bilateral Babinski’s signs were negative.
Peripheral blood analysis showed a leukocyte count of
4500/μL, hemoglobin 12.1 g/dL, platelet count 251,000/
μL, and C-reactive protein 16 mg/L(normal range, 0.0–
8.0 mg/L). His serum sodium was 127 mmol/L(normal
range, 135–145 mmol/L). The pharyngeal swab sample
detected M.pneumoniae DNA copies 1.1 × 104 per mL by
using polymerase chain reaction (PCR). Specific serum M.
pneumoniae antibodies (IgM) were positive at a titre of
1.71 on the sixth day of the disease (ELISA, normal
value:< 1.1). Specific serum IgM antibodies (ELISA)
against chlamydia, herpes simplex virus, varicella zoster,
cytomegalovirus, Epstein-Barr virus, rubella, toxoplasma,
influenza A and B, measles virus, adenovirus, and Japanese
encephalitis virus infections were negative. The PCR was
negative for influenza A and B in pharyngeal swab. Rota-
virus antigen was not detected in his stool specimen.
Other blood biochemical tests and urine analysis were
normal. The cytokines were not assessed in the serum and
cerebrospinal fluid (CSF). CSF was normal with 2 white
cell/mL, 20.1 mg/dL protein, and 70.6 mg/dL glucose. M.
pneumoniae and herpes simplex virus PCR analyses in
CSF were negative. The electroencephalogram (EEG)
revealed diffuse slow waves. Cranial MRI showed a focal
high-signal lesion in the splenium of the corpus callosum
on diffusion-weighted and T2-weighted images on the day
of admission (Fig. 1a, b).
After admission, treatment included acyclovir (10 mg/
kg 8 hourly) for herpes viruses infection before the
M.pneumoniae infection was confirmed, mannitol (5 ml/
kg 8 hourly) for reduction of intracranial pressure, dexa-
methasone(0.4 mg/kg/d) for reduction of facial nerve
swelling, and methycobal (1000 mg/d) for facial nerve
paralysis. After M.pneumoniae infection was confirmed,
azithromycin (10 mg/kg/day) was administered for
5 days. The symptoms improved significantly. Two days
after admission, the patient no longer had lethargy,
headache, vomiting, and had normal body temperature.
Four days after admission, the patient showed improve-
ment in mouth drooping on the right side, incomplete
eyelid closure, and stabilization of the rash. Seven days
after admission, his serum sodium was 135 mmol/L and
his EEG was normal. Re-examination of the cranial MRI,
he had normal MRI signals in the corpus callosum
(Fig. 1c, d). Ten days after admission, the patient was
discharged with excellent mental status, no obvious
mouth drooping, substantially restored ability to close
the left eyelid, and no rash.
Case 2
A 12-year-old male patient was admitted to the hospital
because of fever for 6 days, and headache, dizziness,
vomiting, and cough for 4 days. Physical examination
showed a body temperature of 38 °C and otherwise nor-
mal vital signs. The breath sound in the right lower lung
was low. Neurological examination showed poor mental
status and obvious lethargy. Cranial nerve examination
did not reveal abnormal findings. Meningeal irritation
and bilateral Babinski’s signs were negative.
Peripheral blood analysis showed a leukocyte count of
8100/μL, hemoglobin 13.0 g/dL, platelet count 253,000/
μL, and C-reactive protein 14 mg/L. His serum sodium
was 139 mmol/L. The sputum sample detected M.pneu-
moniae DNA copies 1.25 × 104 per mL through the PCR.
Specific serum M. pneumoniae antibodies (IgM) were
Fig. 1 MRI findings of case 1. Diffusion-weighted image (a) and T2-
weighted image (b) on the day of admission showed a focal high-signal
lesion in the splenium of the corpus callosum (arrow). On the seventh
day after admission, the splenial lesion had completely disappeared on
diffusion-weighted image (c) and T2-weighted image (d)
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positive at a titre of 2.11 on the seventh day of the dis-
ease (ELISA, normal value:< 1.1). The above viruses IgM
antibodies were also negative. The PCR was negative for
influenza A and B in sputum sample and rotavirus anti-
gen was also not detected in his stool specimen. Blood
biochemical tests did not show abnormal findings. Cyto-
kines levels were examined in serum and CSF. The re-
sults revealed the concentration of interleukin-6(IL-6)
was normal in serum and moderately increased in the
CSF. The concentration of IL-6 in the serum and CSF
was 9 pg/mL and 101 pg/mL(ELISA, normal range <
10 pg/mL), respectively. The levels of other cytokines
were normal in serum and CSF. The CSF examination
showed no abnormalities. M. pneumoniae and herpes
simplex virus PCR analyses in CSF were also negative.
X-ray suggested right lower lobe pneumonia. The EEG
also demonstrated global diffuse slow waves. Cranial
MRI showed a focal high-signal lesion in the splenium
of the corpus callosum on T2-weighted and fluid-
attenuated inversion recovery (FLAIR) images on the
day of admission (Fig. 2a, b).
After admission, acyclovir (10 mg/kg 8 hourly) was
used for herpes viruses infection. After M. pneumoniae
infection was confirmed, azithromycin (10 mg/kg/day)
was administered for 5 days. Mannitol (5 ml/kg 8
hourly) was used to decrease the intracranial pressure.
Two days after admission, the patient showed an im-
provement in disturbed consciousness and reduced
headaches, dizziness, and vomiting. Three days after
admission, the patient had normal mental status, normal
body temperature, and apparent cough relief. Eight days
after admission, the patient was discharged with excel-
lent mental status, no obvious cough, normal EEG find-
ings, and no abnormal MRI signals in the corpus
callosum (Fig. 2c, d).
Discussion
MERS is characterized by acute mild symptoms of en-
cephalopathy occurring during an acute inflammatory
disease process. Brain MRIs show characteristic changes
in the corpus callosum, and recovery occurs without
special treatment. MERS is divided into type 1 (damage
limited to the splenium of the corpus callosum on MR
images) and type 2 (damage spread to the entire corpus
callosum or adjacent white matter or both) [8]. Type 1
MERS is more common.
Most currently reported MERS cases are concentrated
in East Asia, especially in Japan, and in children [2, 9].
The most common pathogens are viruses (rotavirus,
measles virus, adenovirus, and especially influenza virus)
and a few bacteria (Table 1)[3, 9]. However, cases of
M.pneumoniae infection-induced MERS are relatively
rare. M.pneumoniae is a common pathogen of respira-
tory tract infection in children. Therefore, studying path-
ogens including M.pneumoniae can help us understand
the etiology and pathogenesis of MERS. CNS disorders
such as encephalitis, meningitis, cerebellitis, and myelitis
are common extrapulmonary manifestations of M.pneumo-
niae infection, which can also damage the skin and mucosa.
However, MERS has not been reported among M.pneumo-
niae-related CNS dysfunction. In the present study, both
patients had clinical and imaging manifestations of MERS
after M.pneumoniae infection, and according to MRI
Fig. 2 MRI findings of case 2. T2-weighted image (a) and FLAIR
image (b) on the day of admission showed a focal high-signal lesion
in the splenium of the corpus callosum (arrow). On the eighth day
after admission, the splenial lesion had completely disappeared on
T2-weighted image (c) and FLAIR image (d)
Table 1 Pathogens of MERS in the literature
Authors No. of
patients
Pathogens of MERS (no. of patients)
Hoshino et al.
[9]
153 Influenza (53), rotavirus (18), mumps virus (6),
HHV-6 (3), bacterial infection (5)
Takanashi [2] 54 Unknown (22), influenza A/B (6/4), mumps
virus (4), adenovirus (3), rotavirus (3),
streptococcus (3), Escherichia coli (3)
Tada et al [1] 15 Unknown (10), influenza A (1), adenovirus (1),
mumps virus (1), VZV virus (1)
Ka A et al. [11] 7 Unknown (3), influenza B (1), adenovirus (1),
CMV virus (1), Salmonella (1)
Bulakbasi et al.
[15]
5 Influenza A (5)
Ganapathy et al.
[16]
2 Influenza B (2)
Takanashi et al.
[14]
4 Kawasaki desease (4)
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findings, were diagnosed as having type 1 MERS. Notebaert
et al. [5] and Zhao et al. [6] each reported 1 case of M.pneu-
moniae infection-induced type 2 MERS, respectively, and
Shibuya et al. [4] reported 1 adult case of M.pneumoniae
infection-induced type 1 MERS. However, little has been
reported about child cases of M.pneumoniae infection-
induced type 1 MERS. In the present study, case 1 had
symptoms of not only MERS but also peripheral facial
nerve paralysis and rash. To the best of our knowledge, it is
the first MERS case associated with peripheral nerve dam-
age, although the peripheral facial paralysis is known to be
associated with M.pneumoniae infection [10]. This case
shows that M.pneumoniae infection can cause damage to
multiple systems and enriches the spectrum of clinical
manifestations of MERS.
The pathogenesis of MERS remains unclear. Possible
mechanisms include transient intramyelinic edema,
interstitial axonal edema, and inflammatory infiltration
due to a myelin specific neurotoxin released by the
pathogen [1, 2, 11], thus resulting in the transiently
reduced diffusion seen on MRI. Takanashi et al. [12]
suggested that the process of MERS may involve hypo-
natremia. Hyponatremia reduces the intracellular os-
motic pressure in the splenium of the corpus callosum
to facilitate free water entry, leading to transient cerebral
edema. In the present study, the early serum sodium
level was 127 mmol/L in case 1 and normal in case 2. In
addition, the serum sodium level in the case of type 2
MERS reported by Zhao et al. [6] was also within the
normal range. It suggests the possible but not essential
involvement of hyponatremia in the pathogenesis of
M.pneumoniae-induced MERS. Some other investigators
have suggested the involvement of cytokines. Mori
et al. [13] found that the CSF level of IL-6 increased sig-
nificantly in a child with rotavirus-related MERS, while
serum level of interleukin-1β, IL-6, interleukin-8, and
tumor necrosis factor-α also increased in MERS children
with Kawasaki disease [14], suggesting that the patho-
genesis of MERS may involve the activation of the im-
mune system. In the present study, IL-6 was moderately
increased in the CSF of patient 2, but was not assessed
in the serum and CSF of patient 1. Accordingly, we
speculate that IL-6 may be involved in M.pneumoniae-
induced MERS, but verification of more cases is needed.
MERS, especially type 2 MERS, should be distinguished
from other leukoencephalopathies such as acute dissemi-
nated encephalomyelitis (ADEM), reversible posterior
leukoencephalopathy syndrome (RPLS), and hereditary
leukoencephalopathy. In particular, ADEM has clinical
manifestations similar to those of MERS during its early
stage. However, their MRI findings are different. In
ADEM, lesions are distributed asymmetrically and most
obvious in the T2-weighted sequence; diffusion is not
restricted; enhancement can be observed after use of
contrast agents, and the corpus callosum is less likely
involved. On the contrary, in MERS, the corpus callosum
is often involved symmetrically; the white matter damage
is also symmetrical, and diffusion is significantly restricted
without enhancement [11]. Through differential diagnosis,
MERS can be diagnosed in a timely and precise manner
to avoid overtreatment.
Conclusions
In conclusion, we reported two paediatric cases of type I
MERS with coinciding M. pneumoniae detection. Our
study enriches the available information on the pathogens
of MERS and provides valuable data for better under-
standing of this syndrome. Recognizing this syndrome
early in children can avoid overtreatment and provide
reassurance about the good prognosis of the disease.
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